2Eichholzer M, Tonz O, Zimmermann R. Folic acid:a public-- health challenge[J]. Lancet,2006,367(9519) : 1352-61.
3Li Z, Ren A, Zhang L, et al. Periconceptional use of folic acidin Shanxi province of northen China[J]. Public Health Nutr, 2007,10(5):471-476.
4Conlin ML,MacLennan AH,Broadbent JL. Inadequate com- pliance with periconeeptional folio acid supplementation in South Australia[J]. Aust N Z J Obstet Gynaecol, 2006,46 (6):528-533.
5Botto LD,Lisi A,Bower C,et aL. Trends of selected mal- formations in relation to folic acid recommendation and forti- fication: an internation assessment[J]. Birth Defects Res A Clin Mol Teratol, 2006,76 :693-705.
6Coll O,Pisa S, Palacio M,et aL. Awareness of the use of folio acid to prevent neural tube defects in a Mediterranean area[J]. Eur J Obstet Gynecol Reprod Biol, 2004,115 (2):173-177.
7Chivu CM, Tulchinsky TH, Soares- Weiser K, et aL. A systematic review of interventions to increase awareness, knowledge, and folic acid consumption before and during pregnancy[J]. Am J Health Promot, 2008,22 (4):237-245.
8中华人民共和国卫生部.中国出生缺陷防治报告[R].北京:中华人民共和国卫生部,2012.
9Czeizel AE, Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation[J]. N Engl J Med, 1992, 327(26):1832- 1835.
10Lumley J, Watson L, Watson M, et al. Periconeeptional supplementa- tion with folate and/or multivitamins for preventing neural tube defects [J]. Cochrane Database Syst Rev, 2001, CD001056.
